Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

Page

Kaposi Sarcoma (Infectious Disease) - Drugs in Development, 2021

By Global Markets Direct | Pharmaceuticals and Healthcare | Oct 2021 | Page 468

Kaposi Sarcoma (Infectious Disease) - Drugs in Development, 2021 Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Kaposi Sarcoma - Drugs In Development, 2021, provides an overview of the....

USD 2000 View Report

Herpes Labialis (Oral Herpes) (Infectious Disease) - Drugs in Development, 2021

By Global Markets Direct | Pharmaceuticals and Healthcare | Oct 2021 | Page 61

Herpes Labialis (Oral Herpes) (Infectious Disease) - Drugs in Development, 2021 Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Herpes Labialis - Drugs In Development, 2021, provides an overview....

USD 2000 View Report

Respiratory Syncytial Virus (RSV) Infections (Infectious Disease) - Drugs in Development, 2021

By Global Markets Direct | Pharmaceuticals and Healthcare | Oct 2021 | Page 380

Respiratory Syncytial Virus (RSV) Infections (Infectious Disease) - Drugs in Development, 2021 Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Respiratory Syncytial Virus Infections - Drugs In Development, 2021,....

USD 2500 View Report

Progressive Multifocal Leukoencephalopathy (Infectious Disease) - Drugs in Development, 2021

By Global Markets Direct | Pharmaceuticals and Healthcare | Oct 2021 | Page 47

Progressive Multifocal Leukoencephalopathy (Infectious Disease) - Drugs in Development, 2021 Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Progressive Multifocal Leukoencephalopathy - Drugs In Development, 2021, provides an overview....

USD 2000 View Report

Rubella (German Measles) (Infectious Disease) - Drugs in Development, 2021

By Global Markets Direct | Pharmaceuticals and Healthcare | Oct 2021 | Page 44

Rubella (German Measles) (Infectious Disease) - Drugs in Development, 2021 Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Rubella (German Measles) - Drugs In Development, 2021, provides an overview....

USD 2000 View Report